Suvorexant (Belsomra® Tablets 10, 15, and 20 mg): Japanese Drug-Use Results SurveyYuko Asai, Mitsuyoshi Hara, Yoshikazu Maeda et al.|Drugs in R&D|2018Cited by 22
Safety profile and clinical course of patients with insomnia administered suvorexant by initial treatment status in a post-marketing surveyHideki Sano, Mitsuyoshi Hara, Yoshikazu Maeda et al.|Expert Opinion on Drug Safety|2019Cited by 9
Safety and efficacy of suvorexant in a real world setting: interim results from the drug use-results survey in JapanMakoto Miyazaki, Mitsuyoshi Hara, Yuko Asai et al.|Sleep Medicine|2017Cited by 0
0442 Safety and Efficacy of Suvorexant in a Real World Setting: Results from the Drug Use-results Survey in JapanMakoto Miyazaki, Mitsuyoshi Hara, Yuko Asai et al.|SLEEP|2018Cited by 0
Safety profile and clinical course of patients with insomnia administered suvorexant by initial treatment status in a post-marketing surveyHideki Sano, Mitsuyoshi Hara, Mika Iwakura et al.|Figshare|2019Cited by 0